Brady W. Dougan - Nov 19, 2024 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director
Signature
/s/ Brady W. Dougan by Dale A. Sander as Attorney-in-Fact
Stock symbol
HUMA
Transactions as of
Nov 19, 2024
Transactions value $
$7,979
Form type
4
Date filed
11/21/2024, 07:30 AM
Previous filing
Nov 20, 2024
Next filing
Dec 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Purchase $7.98K +1.8K +0.74% $4.44 244K Nov 19, 2024 By spouse F1, F2
holding HUMA Common Stock 510K Nov 19, 2024 Direct
holding HUMA Common Stock 1.73M Nov 19, 2024 By Ayabudge LLC
holding HUMA Common Stock 1.15M Nov 19, 2024 By The Niklason Living Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This purchase by the Reporting Person's spouse is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, against a portion of the sale by Ayabudge LLC, an entity controlled by the Reporting Person, of 809,786 shares of the Issuer's common stock on May 31, 2024. The Reporting Person's spouse has paid the Issuer $8,778.23, representing the full amount of profit realized in connection with this purchase.
F2 The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $4.435 to $4.4352. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.